| __timestamp | Amgen Inc. | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 4297000000 | 56292000 |
| Thursday, January 1, 2015 | 4070000000 | 74277000 |
| Friday, January 1, 2016 | 3840000000 | 122721000 |
| Sunday, January 1, 2017 | 3562000000 | 109749000 |
| Monday, January 1, 2018 | 3737000000 | 145283000 |
| Tuesday, January 1, 2019 | 4116000000 | 131711000 |
| Wednesday, January 1, 2020 | 4207000000 | 181157000 |
| Friday, January 1, 2021 | 4819000000 | 272744000 |
| Saturday, January 1, 2022 | 4434000000 | 397518000 |
| Sunday, January 1, 2023 | 4784000000 | 571011000 |
| Monday, January 1, 2024 | 5964000000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, innovation is the key to staying ahead. Amgen Inc. and Insmed Incorporated, two giants in the field, have shown distinct strategies in their research and development (R&D) investments over the past decade. From 2014 to 2023, Amgen consistently outpaced Insmed, investing nearly 20 times more in R&D annually. In 2023, Amgen's R&D expenses reached approximately $4.8 billion, a 10% increase from 2014, while Insmed's investment grew significantly by over 900%, reaching $571 million. This stark contrast highlights Amgen's robust financial commitment to innovation, while Insmed's rapid growth in R&D spending underscores its aggressive push to expand its research capabilities. As the biotech industry evolves, these investment trends will likely shape the future breakthroughs and market positions of these companies.
Who Prioritizes Innovation? R&D Spending Compared for Merck & Co., Inc. and Insmed Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Analyzing R&D Budgets: Amgen Inc. vs Zoetis Inc.
Research and Development Expenses Breakdown: Amgen Inc. vs Genmab A/S
Research and Development Expenses Breakdown: Amgen Inc. vs Madrigal Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amgen Inc. vs Catalyst Pharmaceuticals, Inc.
Amgen Inc. or ACADIA Pharmaceuticals Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Iovance Biotherapeutics, Inc.
Gilead Sciences, Inc. vs Insmed Incorporated: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Viatris Inc. vs Insmed Incorporated
Analyzing R&D Budgets: Insmed Incorporated vs Sarepta Therapeutics, Inc.
Comparing Innovation Spending: Insmed Incorporated and Ligand Pharmaceuticals Incorporated